April 3, 2023 02:25 PM EDT
Pharma
Law

San­doz to pay Al­ler­gan, Duke Uni­ver­si­ty $39M over eye drug law­suit, ju­ry says

Katherine Lewin

News Reporter

San­doz is on the hook for $39 mil­lion to Al­ler­gan and Duke Uni­ver­si­ty for in­fring­ing on their patent for an eye­lash-growth drug, Latisse (bi­mato­prost oph­thalmic …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: CEO of Unit­ed­Health in­sur­ance unit shot and killed in New York in what po­lice call ‘a brazen, tar­get­ed ...

Blue­bird and Ver­tex's sick­le cell gene ther­a­pies to kick off new Med­ic­aid ac­cess mod­el

Lil­ly beats No­vo in bell­wether head-to-head weight loss study

As 23andMe strug­gles, an­oth­er ge­net­ic test­ing com­pa­ny bets on drug dis­cov­ery

Mod­er­na CEO de­fends pan­dem­ic prep ef­forts with crit­ics set to en­ter Trump’s ad­min­is­tra­tion

Trade group tells FDA that semaglu­tide is not too 'com­plex' for com­pound­ing

A service from the Financial Times